Live Breaking News & Updates on லிசா கொண்டே

Stay updated with breaking news from லிசா கொண்டே. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Jaguar Health, Inc.: Jaguar Health Signs Second Agreement for $6 Million Non-dilutive Financing Transaction Involving the Sale of Royalty Rights Related to Future Mytesi (Crofelemer) and Lechlemer Revenue Stream


(2)
No royalty payments due for 18-24 months
Proceeds will be allocated to support regulatory activities associated with the Company s development pipeline, including funding the recently initiated pivotal clinical trial for crofelemer (Mytesi
®) for cancer therapy-related diarrhea (CTD), for which patient enrollment is progressing
SAN FRANCISCO, CA / ACCESSWIRE / December 23, 2020 / Jaguar Health, Inc. (NASDAQ:JAGX) ( Jaguar or the Company ) today announced that the Company has signed an agreement (the Agreement ) with a secured lender (the Lender ) for a non-dilutive royalty financing transaction, pursuant to which Jaguar would sell to the Lender for an aggregate purchase price of $6 million (the Royalty Purchase Price ) a royalty interest entitling the Lender to receive 2.0x the Royalty Purchase Price of future royalties of Mytesi ....

Lisa Conte , Peter Hodge , Jaguar Health Inc , Napo Pharmaceuticals Inc , Jaguar Health , Royalty Purchase Price , Royalty Repayment Amount , Napo Pharmaceuticals , Prescribing Information , லிசா கொண்டே , பீட்டர் ஹாட்ஜ் , ஜாகுவார் ஆரோக்கியம் இன்க் , நாபொ மருந்துகள் இன்க் , ஜாகுவார் ஆரோக்கியம் , ராயல்டி கொள்முதல் ப்ரைஸ் , நாபொ மருந்துகள் , ப்ரிஸ்க்ரைபிஂக் தகவல் ,